BiotechTube

Micafungin + Placebo

Phase 3Terminated
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Invasive Fungal Infections

Conditions

Invasive Fungal Infections

Trial Timeline

Jan 1, 2003 → Jun 1, 2003

NCT ID
NCT00048750

About Micafungin + Placebo

Micafungin + Placebo is a phase 3 stage product being developed by Astellas Pharma for Invasive Fungal Infections. The current trial status is terminated. This product is registered under clinical trial identifier NCT00048750. Target conditions include Invasive Fungal Infections.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT01122368Phase 2Completed
NCT00048750Phase 3Terminated

Competing Products

20 competing products in Invasive Fungal Infections

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
41
pegylated liposomal doxorubicin (PLD) + PD-1CSPC Pharmaceutical Group LimitedPhase 2
51
Trastuzumab deruxtecan + DurvalumabDaiichi SankyoPhase 2
52
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
77
Micafungin + fluconazoleAstellas PharmaPhase 3
77
MicafunginAstellas PharmaPre-clinical
23
Micafungin (Mycamine)Astellas PharmaPhase 1
33
Pudexacianinium chlorideAstellas PharmaPhase 2
52
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
52
Enfortumab Vedotin + PembrolizumabAstellas PharmaPhase 2
52
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
23
Pembrolizumab + Enfortumab VedotinAstellas PharmaPhase 3
77
Isavuconazonium sulfate + Isavuconazonium sulfateAstellas PharmaPhase 2
52
Micafungin + Systemic antifungal therapyAstellas PharmaPhase 2
52
MicafunginAstellas PharmaPre-clinical
23
MicafunginAstellas PharmaApproved
85
Olorofim + AmBisome®ShionogiPhase 3
77
Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel + Epirubicin or doxorubicin, cyclophosphamide, paclitaxelJiangsu Hengrui MedicinePhase 3
77
SHR-A1811 + Trastuzumab EmtansineJiangsu Hengrui MedicinePhase 3
77
Herombopag tablets + Herombopag placebo tabletsJiangsu Hengrui MedicinePhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85